ÍøºìºÚÁÏ

Skip to main content

William Slayton, MD : Research

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of William Slayton

Research at a glance

Top areas of exploration

  • Hematopoietic Stem Cells , 12 publications
  • Bone Marrow Transplantation , 10 publications
  • Bone Marrow Cells , 9 publications
  • Hematopoietic Stem Cell Transplantation , 8 publications

Research activity

86 publications

2,301 citations

Why is this important?

Active clinical trials

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other…

Investigators
Brian Stover, William Slayton
Status
Accepting Candidates
Ages
3 Years - 29 Years
Sexes
All

My publications

86 publications

2014

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.

International journal of radiation oncology, biology, physics

•

2014

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

Leukemia

•

2014

Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.

Leukemia

•

2013

Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans.

PloS one

•

2013

Molecular mechanisms of platelet and stem cell rebound after 5-fluorouracil treatment.

Experimental hematology

•